Botulinum toxin type A inhibits microglia pyroptosis by suppressing Cblb-mediated degradation of Pdlim1 to attenuate neuropathic pain
Abstract Background Microglia pyroptosis, a newly identified form of inflammatory cell death, is involved in the development of neuropathic pain (NP). Botulinum toxin type A (BTX-A) has been shown to be effective in relieving NP, but the mechanisms involved have not been clarified. Methods A mice mo...
Saved in:
| Main Authors: | Sheng Tian, Lanxiang Wu, Heqing Zheng, Zhijuan Cheng, Jingjing Liu, Mingxu Liu, Xinping Yu, Jianglong Tu, Wei Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | The Journal of Headache and Pain |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10194-025-02109-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Co‐recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR‐induced ubiquitylation
by: Guillaume Voisinne, et al.
Published: (2016-07-01) -
Interleukin-4 induces CD11c+ microglia leading to amelioration of neuropathic pain in mice
by: Keita Kohno, et al.
Published: (2025-08-01) -
OTUD1 exacerbates sepsis-associated encephalopathy by promoting HK2 mitochondrial release to drive microglia pyroptosis
by: Guoqing Jing, et al.
Published: (2025-06-01) -
Pharmacological inhibition of the cGAS-STING pathway suppresses microglia pyroptosis in sepsis-associated encephalopathy
by: Qing-quan Zeng, et al.
Published: (2025-07-01) -
Neuropathic pain: proposal of a mechanism-based treatment
by: Laura Demartini, et al.
Published: (2025-04-01)